NCT02066207View on ClinicalTrials.gov

CKD-337 Drug Interaction Study

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 18, 2014

Primary Completion Date

April 7, 2014

Study Completion Date

May 29, 2014

Conditions
Dyslipidemia (Fredrickson Type Ⅱa)Dyslipidemia (Fredrickson Type Ⅱb)
Interventions
DRUG

Fenofibrate

DRUG

Atorvastatin

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY